Alpha-9 becomes latest radiopharma to secure funds with $175m …

Oct 24, 2024 · This latest financing comes after a flood of investment into the radiopharma …

CouponFollow Extension

$175
OFF

Alpha-9 Becomes Latest Radiopharma To Secure Funds With $175m …

4 weeks from now

Oct 24, 2024 · This latest financing comes after a flood of investment into the radiopharma …

pharmaceutical-technology.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024 · BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – …

a9oncology.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024 · Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company …

yahoo.com

$175
OFF

Radiopharma Startup Alpha-9 Nets $175M Series C

4 weeks from now

Oct 24, 2024 · In the latest deal for the red-hot radiopharmaceutical field, Alpha-9 Oncology …

insideprecisionmedicine.com

$175
OFF

Alpha-9 Oncology Secures $175 Million In Oversubscribed Series C …

4 weeks from now

Oct 24, 2024 · Furthermore, the Series C will fund expanded R&D capabilities and continued …

readmagazine.com

$175
OFF

Alpha-9 Oncology Secures $175M Series C To Drive …

4 weeks from now

Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology …

jacobsmgt.com

$175
OFF

Alpha-9 Oncology Raises $175M In Series C Financing

4 weeks from now

Oct 23, 2024 · Alpha-9 Oncology Inc., a Boston, MA- and Vancouver, Canada-based clinical …

finsmes.com

$175
OFF

Alpha-9's $175m Third-round Heads Latest Biotech Financings

4 weeks from now

Oct 31, 2024 · Radiopharma start-up Alpha-9 Oncology has closed a sizeable third investment …

pharmaphorum.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024 · BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 …

cnhinews.com

$175
OFF

Radiopharma Biotech Alpha-9 Oncology Closes $175M Series C …

4 weeks from now

Oct 23, 2024 · Another private radiopharmaceutical biotech has raised big money. Alpha-9 …

endpts.com

$175
OFF

Alpha-9 Oncology, Inc. - Drug Pipelines, Patents, Clinical Trials

4 weeks from now

Alpha-9 becomes latest radiopharma to secure funds with $175m Series C. Alpha-9 Oncology …

patsnap.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

BOSTON and VANCOUVER, BC, October 23, 2024-- Alpha-9 Oncology Inc. (Alpha-9 or the …

vcaonline.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 24, 2024 · Furthermore, the Series C will fund expanded R&D capabilities and continued …

lifesciencesbc.ca

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha …

epicos.com

FAQs about Alpha-9 becomes latest radiopharma to secure funds with $175m … Coupon?

Is alpha-9 a good radiopharmaceutical company?

“Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. “The Series C is an exciting, significant milestone for us and will greatly accelerate our growth. ...

Why did alpha-9 announce a $175 million Series C financing?

BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

What is alpha-9 oncology doing with $175m in Series C funding?

The company will use the funds to advance its pipeline of cancer-targeting preclinical candidates to the “clinic-ready” stage. Alpha-9 Oncology has raised $175m in a Series C funding round to advance its pipeline of radiopharmaceuticals. Credit: eamesBot via Shutterstock. ...

Who is alpha-9 oncology?

Credit: eamesBot via Shutterstock. Alpha-9 Oncology is the latest radiopharma to raise funds, drawing in $175m in Series C financing, to advance its radiopharmaceutical candidates through clinical trials and expand its research and development (R&D) capabilities. ...

How does alpha-9 work?

To support its endeavors, Alpha-9 has purpose-built research facilities in Vancouver, which were completed last year and have been operating at scale. These facilities help to accelerate drug development by streamlining discovery processes. Alpha-9 has also partnered with isotope suppliers and CDMOs to support its ongoing clinical trials. ...

Why should you invest in a series C of alpha-9?

Furthermore, the Series C will fund expanded R&D capabilities and continued investment in CMC and supply chain. “Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. ...